Eric S. Schafer

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma

David T. Teachey, Meenakshi Devidas, Brent L. Wood et al. · Journal of Clinical Oncology · 2022 · 148 citations · Full text

Medicine, Oncology, Pharmacology +17

Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting

Eric S. Schafer, Rafael A. Irizarry, Sandeep Negi et al. · Blood · 2010 · 119 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)

Eric S. Schafer, Rachel E. Rau, Stacey L. Berg et al. · Pediatric Blood & Cancer · 2019 · 93 citations · Full text

Medicine, Oncology, Pharmacology +17

Decitabine and vorinostat with <scp>FLAG</scp> chemotherapy in pediatric relapsed/refractory <scp>AML</scp>: Report from the therapeutic advances in childhood leukemia and lymphoma (<scp>TACL</scp>) consortium

Lauren Pommert, Eric S. Schafer, Jemily Malvar et al. · American Journal of Hematology · 2022 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism

Julienne Brackett, Eric S. Schafer, Daniel H. Leung et al. · Pediatric Blood & Cancer · 2013 · 35 citations

Pharmacy, Pharmacology, Pharmacotherapy +15